Atlas Trials

Recurrent Intraocular Melanoma

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Intraocular Melanoma

RecordFirmDate
Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases (NCT01730157)Case Comprehensive Cancer Center2012-12-01
Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery (NCT01533948)Roswell Park Cancer Institute2012-01-01
Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye (NCT01413191)National Cancer Institute (NCI)2011-08-01
Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye (NCT00329641)National Cancer Institute (NCI)2011-02-01
Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance (NCT01100528)Case Comprehensive Cancer Center2009-11-11
VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery (NCT00450255)National Cancer Institute (NCI)2007-06-01
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma (NCT00288041)National Cancer Institute (NCI)2005-10-01
Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma (NCT00121225)National Cancer Institute (NCI)2005-09-01
Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma (NCT00085189)University of Southern California2004-05-01
Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye (NCT00020475)National Cancer Institute (NCI)2001-02-01

Track Recurrent Intraocular Melanoma automatically

Every clearance here is in the API, with alerts when new ones post.